Human medicines European public assessment report (EPAR): Absimky, ustekinumab, Date of authorisation: 12/12/2024, Revision: 4, Status: Withdrawn
Agenda - Management Board meeting: 17-18 December 2025
Minutes of the PRAC meeting 27 - 30 October 2025
Human medicines European public assessment report (EPAR): Azacitidine Kabi, azacitidine, Date of authorisation: 05/01/2024, Revision: 2, Status: Authorised
Fiasp PumpCart (insulin aspart)
Name Review Group form - questions and answers
NovoRapid PumpCart (insulin aspart)
Allergen products development for immunotherapy and allergy diagnosis in moderate to low-sized study populations - Scientific guideline
Human medicines European public assessment report (EPAR): Invokana, canagliflozin, Date of authorisation: 15/11/2013, Revision: 27, Status: Authorised
EMA/PE/0000232894